CTX
CAPTOR THERAPEUTICS GPW LISTED

Shareholders

as of June 30, 2026 · source: notifications under Art. 69 of the Offering Act · 5 entities above 5% of votes

FREE FLOAT
55.6%
3,532,068 shares
LARGEST STAKE
14.42%
Michał Walczak
TOP 3 CONCENTRATION
31.87%
3 entities above 5% of votes
LATEST CHANGE
June 19, 2026
ESPI (wykaz z WZ)

Ownership structure

stakes per latest notifications · shares outstanding: 6,353,397 (report, Jun 30, 2026)
SHAREHOLDERS ≥5% OF VOTES 44.4% FREE FLOAT 55.6%
Michał Walczak 14.42%
916,028 shares NOTIFICATION: Jun 30, 2026
Paweł Holstinghausen Holsten 9.51%
604,065 shares NOTIFICATION: Jun 30, 2026
Fundusze Zarządzane przez PTE Allianz Polska S.A. 7.94%
504,468 shares NOTIFICATION: Jun 30, 2026
Fundusze Zarządzane przez PKO BP Bankowy PTE S.A. 6.84%
434,771 shares NOTIFICATION: Jun 30, 2026
Sylvain Cottens 5.38%
341,997 shares NOTIFICATION: Jun 30, 2026
Captor Therapeutics S.A. – akcje własne 0.31%
20,000 shares NOTIFICATION: Jun 30, 2026
FREE FLOAT — BELOW 5% OF VOTES
Fundusze Zarządzane przez TFI Allianz Polska S.A. 5.41%
343,483 shares NOTIFICATION: Jun 30, 2026
Fundusze Zarządzane przez Nationale-Nederlanden PTE S.A. 4.77%
303,075 shares NOTIFICATION: Jun 30, 2026
Other 45.42%
2,885,510 shares composition undisclosed

Capital and votes

Number of shares
6,353,397
ISIN
PLCPTRT00014
Sector
Biotechnologia
Market
GPW
Country
PL
Listing date
April 01, 2021

Where this data comes from

The structure is built from notifications shareholders file after crossing 5%, 10%, 15%, 20%, 25%, 33%, 50%, 75% and 90% of votes.

Below 5% there is no disclosure obligation, so the remaining capital is shown collectively as free float — its composition is not publicly known.

Stakes are not updated in real time. The date next to each entity is its last notification date, not today's date.

The share count behind every percentage comes from the newest (by as-of date) periodic report or art. 69 notification — not from the company's GPW/NewConnect profile.